Cargando…

Diabetes mellitus y riesgo cardiovascular: recomendaciones del Grupo de Trabajo Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED, 2015)()

The present paper updates the Clinical Practice Recommendations for the management of cardiovascular risk factors (CVRF) in diabetes mellitus. This is a medical consensus agreed by an independent panel of experts from the Spanish Society of Diabetes (SED). Several consensuses have been proposed by s...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrieta, Francisco, Iglesias, Pedro, Pedro-Botet, Juan, Tébar, Francisco Javier, Ortega, Emilio, Nubiola, Andreu, Pardo, Jose Luis, Maldonado, Gonzálo Fernando, Obaya, Juan Carlos, Matute, Pablo, Petrecca, Romina, Alonso, Nuria, Sarabia, Elena, Sánchez-Margalet, Victor, Alemán, José Juan, Navarro, Jorge, Becerra, Antonio, Duran, Santiago, Aguilar, Manuel, Escobar-Jiménez, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877822/
https://www.ncbi.nlm.nih.gov/pubmed/26031458
http://dx.doi.org/10.1016/j.aprim.2015.05.002
Descripción
Sumario:The present paper updates the Clinical Practice Recommendations for the management of cardiovascular risk factors (CVRF) in diabetes mellitus. This is a medical consensus agreed by an independent panel of experts from the Spanish Society of Diabetes (SED). Several consensuses have been proposed by scientific and medical Societies to achieve clinical goals. However, the risk score for general population may lack sensitivity for individual assessment or for particular groups at risk, such as diabetics. Traditional risk factors together with non-traditional factors are reviewed throughout this paper. Intervention strategies for managing CVRF in the diabetic patient are reviewed in detail: balanced food intake, weight reduction, physical exercise, smoking cessation, reduction in HbA1c, therapy for high blood pressure, obesity, lipid disorders, and platelet anti-aggregation. It is hoped that these guidelines can help clinicians in the decisions of their clinical activity. This regular update by the SED Cardiovascular Disease Group of the most relevant concepts, and of greater practical and realistic clinical interest, is presented in order to reduce CVR of diabetics.